Patient-reported outcomes of deferasirox (Exjade®, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis: Substudy of a randomized open-label phase II trial

  • Elliott Vichinsky
  • , Zahra Pakbaz
  • , Onyinye Onyekwere
  • , John Porter
  • , Paul Swerdlow
  • , Thomas Coates
  • , Peter Lane
  • , Beatrice Files
  • , Brigitta U. Mueller
  • , Lena Coïc
  • , Gian Luca Forni
  • , Roland Fischer
  • , Peter Marks
  • , Diana Rofail
  • , Linda Abetz
  • , Jean Francois Baladi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)133-141
Number of pages9
JournalActa Haematologica
Volume119
Issue number3
DOIs
StatePublished - Jun 2008
Externally publishedYes

ASJC Scopus Subject Areas

  • Hematology

Keywords

  • Iron chelation therapy
  • Iron overload
  • Sickle cell disease

Cite this